Food News and Research

RSS

Quest Diagnostics to offer in vitro diagnostic test for use in detection of PD-L1 expression for melanoma

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company.

From Quest Diagnostics 27 Jan 2016

Palonosetron effective anti-emetic for paediatric chemotherapy patients

Palonosetron 20 μg/kg is noninferior to ondansetron for the control of chemotherapy-induced vomiting and nausea during the acute phase of the first treatment cycle in paediatric patients with cancer, research shows.

26 Jan 2016

Better universal healthcare needed to reduce CHE for low-income TB patients in China

Improved universal healthcare is urgently needed to lower catastrophic health expenditure (CHE) for low-income tuberculosis (TB) patients in China, according to a study published in the open access journal Infectious Diseases of Poverty.

25 Jan 2016

BioLineRx's BL-7010 confirmed as Class IIb medical device in European Union

BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received confirmation from the European Notified Body regarding the classification of BL-7010, a novel polymer for the treatment of celiac disease, as a Class IIb medical device in the European Union.

25 Jan 2016

Neurons protect intestinal tissue from over-inflammation

The immune system exercises constant vigilance to protect the body from external threats--including what we eat and drink. A careful balancing act plays out as digested food travels through the intestine. Immune cells must remain alert to protect against harmful pathogens like Salmonella, but their activity also needs to be tempered since an overreaction can lead to too much inflammation and permanent tissue damage.

25 Jan 2016

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.

25 Jan 2016

New humidity sensors could help combat proliferation of bacteria

The Telecommunications Engineer Aitor Urrutia-Azcona has designed some humidity sensors with anti-bacterial properties that combat the proliferation of micro-organisms in environments where the humidity level is very high, such as hospitals and industrial premises for foodstuffs or pharmaceutical products.

25 Jan 2016

Super-spaghetti of enriched pasta could help reduce risk of suffering cardiovascular diseases

Researchers from the University of Granada and the Research and Development of Functional Food Centre (CIDAF, for its initials in Spanish) along with two Italian universities, have developed a 'super-spaghetti' of enriched pasta, elaborated with functional flours, which contains more fibre and proteins than normal pasta and that helps reducing the risk of suffering cardiovascular diseases.

25 Jan 2016

Cardiovascular considerations crucial for CML TKI patients

A review of BCR–ABL1 tyrosine kinase inhibitors highlights the need to consider cardiovascular adverse event risk profiles when prescribing for patients with chronic myeloid leukaemia.

22 Jan 2016

Biomedical innovation in the UK: an interview with Zahid Latif

The biomedical research base is one of the UK's strengths; over 1500 companies in the Pharmaceuticals and biotechnology area are established in the UK employing over 70,000.

22 Jan 2016

Mindfulness could help children avoid obesity

Mindfulness, described as paying attention on purpose and being in the present moment with acceptance, could be an effective way to help children avoid obesity. New research published in the journal Heliyon suggests that the balance in brain networks in children who are obese is different compared to healthy-weight children, making them more prone to over-eating.

22 Jan 2016

FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

Allergan plc, a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the company's supplemental new drug application (sNDA) to update the label for DALVANCE (dalbavancin) for injection.

21 Jan 2016

Centinel Spine reports FDA clearance and first surgical implantation of ALTOS system

Centinel Spine, Inc., announces the U.S. Food and Drug Administration clearance of ALTOS, a posterior cervical thoracic stabilization system indicated for use in either the lateral masses of the cervical spine or the pedicles of the cervical-thoracic spine. The first surgical implantation of the ALTOS system was performed by Gery Hsu, MD, CRMC Medical Associates, Coffeyville, KS on January 4, 2016.

21 Jan 2016

Lilly receives FDA approval for Humulin R U-500 KwikPen

The U.S. Food and Drug Administration has approved Eli Lilly and Company's Humulin R U-500 KwikPen(insulin human injection) 500 units/mL, a pre-filled device containing Humulin R U-500, a highly concentrated formulation of insulin.

21 Jan 2016

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Allergan plc announced today the publication of the positive results of the Phase III trials of VIBERZITM C IV (eluxadoline) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in the January 21 issue of The New England Journal of Medicine.

21 Jan 2016

Parental support programmes could promote healthy eating behaviours in obese children

Parental support programmes in areas with the greatest needs can have a positive effect on the consumption of unhealthy food and drink and on weight increases in obese children. This according to a randomised study conducted by Karolinska Institutet and the Stockholm County Council, Sweden, published in the International Journal of Behavioural Nutrition and Physical Activity.

21 Jan 2016

Weekend junk food binges bad for your gut health

Yo-yoing between eating well during the week and bingeing on junk food over the weekend is likely to be just as bad for your gut health as a consistent diet of junk, new UNSW research suggests.

21 Jan 2016

UM SOM study leads to FDA approval of Neulasta drug for treatment of radiation injury

As a result of research performed by scientists at the University of Maryland School of Medicine, the U.S. Food and Drug Administration has approved the use of a drug to treat the deleterious effects of radiation exposure following a nuclear incident. The drug, Neulasta, is one of a very small number that have been approved for the treatment of acute radiation injury.

21 Jan 2016

Endoscopic sleeve gastroplasty treatment may offer new solution for obese patients

In the fight against obesity, bariatric surgery is currently the most effective treatment; however, only 1 to 2 percent of qualified patients receive this surgery due to limited access, patient choice, associated risks and the high costs. A novel treatment method -- endoscopic sleeve gastroplasty -- might offer a new solution for obese patients.

21 Jan 2016

Eldermark obtains exclusive license to market eMenuCHOICE to senior living and skilled nursing settings

Most adults are accustomed to choosing what they want to eat at each meal. However, when they enter a senior housing or skilled nursing facility, the option to make food choices has traditionally gone away. On the operations side, rising food costs place stress on already tight budgets.

21 Jan 2016

Food News and Research

Quest Diagnostics to offer in vitro diagnostic test for use in detection of PD-L1 expression for melanoma

Palonosetron effective anti-emetic for paediatric chemotherapy patients

Better universal healthcare needed to reduce CHE for low-income TB patients in China

BioLineRx's BL-7010 confirmed as Class IIb medical device in European Union

Neurons protect intestinal tissue from over-inflammation

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

New humidity sensors could help combat proliferation of bacteria

Super-spaghetti of enriched pasta could help reduce risk of suffering cardiovascular diseases

Cardiovascular considerations crucial for CML TKI patients

Biomedical innovation in the UK: an interview with Zahid Latif

Mindfulness could help children avoid obesity

FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

Centinel Spine reports FDA clearance and first surgical implantation of ALTOS system

Lilly receives FDA approval for Humulin R U-500 KwikPen

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Parental support programmes could promote healthy eating behaviours in obese children

Weekend junk food binges bad for your gut health

UM SOM study leads to FDA approval of Neulasta drug for treatment of radiation injury

Endoscopic sleeve gastroplasty treatment may offer new solution for obese patients

Eldermark obtains exclusive license to market eMenuCHOICE to senior living and skilled nursing settings

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News